Article
Real-life application of the optical beta-adrenergic sweat test for people with cystic fibrosis.
Pulmonary pharmacology & therapeutics - 1 Sept 2026
Kleinfelder Karina, Hristodor Anca Manuela, Centin Giorgio, Casiraghi Antonella, Minghetti Paola, Pintani Emily, Bertini Marina, Sorio Claudio, Melotti Paola
Abstract excerpt
Cystic fibrosis (CF) has become increasingly treatable with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-targeted therapies. However, the availability and efficacy of these treatments depend on each patient's CFTR genotype, necessitating careful follow-up to detect effective benefits. This study builds on our previous findings by applying the Optical Beta-Adrenergic Sweat Test (OBAST) as a...
Read the complete abstract on PubMedTopics
- Humans
- Cystic Fibrosis
- Cystic Fibrosis Transmembrane Conductance Regulator
- Sweat
- Male
- Female
